Abstract

Summary

This research demonstrates that the inner blood-retina barrier is a dynamically regulated structure whose permeability cycles throughout the day under circadian control, modulated by local factors including IL-18 and VEGF. These findings have direct clinical implications for the timing of drug delivery to the retina and for understanding dry AMD progression, suggesting that time-of-day may be a critical variable in retinal therapeutics.
Abstract

Key Findings

  • Inner blood-retina barrier (iBRB) permeability was found to cycle periodically throughout the day, with measurable differences in vascular leakage between 8 AM (phagocytically active period) and 8 PM across multiple mouse strains.
  • IL-18 prevented progression of developing neovascular lesions and enhanced regression of fully established lesions in the JR5558 spontaneous neovascularisation mouse model.
  • A novel link was established between daily photoreceptor outer segment (POS) phagocytosis and NLRP3 inflammasome activation in the RPE as part of normal retinal physiology.
  • POS phagocytosis was identified as a potential regulator of VEGF synthesis in retinal homeostasis, connecting circadian phagocytic activity to angiogenic signaling.
  • NLRP3 inflammasome components were confirmed by immunohistochemistry in and around the RPE of human donors diagnosed with geographic atrophy (end-stage dry AMD).
Categories

Categories

Eye Health & Vision: Directly investigates AMD pathology, RPE function, photoreceptor loss, and blood-retina barrier regulation in the context of retinal disease.
The Science of Light: Identifies a novel link between daily photoreceptor outer segment phagocytosis and circadian regulation of inner blood-retina barrier permeability, with measurements at 8 AM vs. 8 PM.
Authors

Author(s)

L Celkova
Publication Date

Publication Year

2019
View more publications